Latest filing published 03 Sept 2026 for Pulmonx Corp, €7,974. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by Glendon E. French III on record concern Pulmonx Corp, in the capacity of board member. Between 15 April 2021 and 1 September 2026, the trades on record add up to 45 filings.
On the market, this insider has only sold: 36 sales, €6.5M in total. The rest of the record consists of 3 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 3 sales.
Most recently, on 3 September 2026, the filings show an open-market sale worth €7,974 in Pulmonx Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations